Latest filing published 12 Dec 2018 for Loxo Oncology, Inc., €12k. Read the official filing
Jennifer Burstein appears in our data through filings on Loxo Oncology, Inc. shares, published by SEC (Form 4). The record holds 102 filings, for trades running from 14 August 2017 to 11 December 2018.
No open-market purchase appears, only 80 sales worth €3.6M. Besides market trades, the filings include 22 option exercises. In 2018 alone, the filings show no purchases and 67 sales.
The record was last updated on 12 December 2018 with an option exercise (€12k) in Loxo Oncology, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 102 declarations